Changing of fecal flora and clinical Effect of L. salivarius LS01 in adults with atopic dermatitis

Journal of Clinical Gastroenterology

Volumn 46, Issue SUPPL. 1, 2012, Pages

  Drago, Lorenzo ^a,b   Toscano, Marco ^a,b   De Vecchi, Elena ^a,b   Piconi, Stefania ^c   Iemoli, Enrico ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

atopic dermatitis; cytokines; probiotics; Th1 cells; Th2 cells

Indexed keywords

PROBIOTIC AGENT;

ADULT; ARTICLE; ATOPIC DERMATITIS; BACTERIAL LOAD; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE TECHNIQUE; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES MICROFLORA; FEMALE; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS SALIVARIUS; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TH1 TH2 BALANCE;

ADOLESCENT; ADULT; CYTOKINES; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; LACTOBACILLUS; MALE; MIDDLE AGED; PROBIOTICS; TH1 CELLS; TH2 CELLS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866245665     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318265ef38     Document Type: Article

References (46)

1. Hanifin J, Saurat JH. Understanding atopic dermatitis: pathophysiology and eziology-introduction. J Am Acad Dermatol. 2001;45(suppl):S1. (Pubitemid 32661813)
2. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007;120:150-155. (Pubitemid 46990506)
3. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology. 1984;86:74-93.
4. Majamaa H, Isoulari E. Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J Allergy Clin Immunol. 1996;97:985-990. (Pubitemid 26116993)
5. Rosenfeldt V, Benfeldt E, Valerius NH, et al. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatrics. 2004;145:612-616. (Pubitemid 39440938)
6. Watanabe S, Narisawa Y, Arase S, et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol. 2003;111:587-581.
7. Lammers KM, Brigidi P, Vitali B, et al. Immunomodulatory effects of prebiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol. 2003;38:165-172. (Pubitemid 37297842)
8. FAO/WHO. Report of a Joint FAO/WHO Expert Consultation: evaluation of health and nutritional properties of probiotics in food including powder milk live lactic acid bacteria; 2002. Available at: http://www:fao.org/es/ESN/food/ foodandfoo-probio-en.stm. Accessed on 2011.
9. Ramakrishna BS. Probiotic-induced changes in the intestinal epithelium: implication in the gastrointestinal disease. Trop Gastroenterol. 2009;30:76-85.
10. Dunne C, Murphy L, Flyn S, et al. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antoine van Leeuwenhoek. 1999;76:279-292. (Pubitemid 29440732)
11. Bjorksten B, Sepp E, Julge K, et al. Allergy development and the intestinal microflora during the first year of life. J Clin Immunol. 2001;108:516-520. (Pubitemid 32978019)
12. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107:129-134. (Pubitemid 32105256)
13. Ouwehand AC, Isolulari E, He F, et al. Differences in bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol. 2001;108:144-145. (Pubitemid 32662250)
14. Wold AE. The hygiene hypothesis revise: is the rising frequency of allergy due to change in the intestinal flora? Allergy. 1998;53:20-25. (Pubitemid 28535340)
15. Bjorksten B. Environmental influence on the development of childhood immunity. Nutr Rev. 1998;56:S106-S112. (Pubitemid 28069976)
16. Matricardi PM, Bonini S. High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the hygiene hypothesis? Clin Exp Allergy. 2000;30:1506-1510.
17. Taylor AL, Dunstan JA, Prescott SL. Probiotics supplementation for the first 6 month of life fails to reduce the risk of atopic dermatitis and increase the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119:184-191. (Pubitemid 46037800)
18. Douek D. HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med. 2007;15:114-117.
19. Kamat A, Ancuta P, Blumberg RS, et al. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS One. 2010;5:e15533.
20. Chun TW, Justement JS, Sanford C, et al. Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. Proc Natl Acad Sci U S A. 2004;101:2464-2469. (Pubitemid 38269334)
21. Vanderhoof JA. Probiotics in allergy management. J Pediatr Gastroenterol Nutr. 2008;47(suppl 2):S38-S40.
22. Rosenfeldt V, Benfeldt E, Nielsen SD, et al. Effect of probiotic Lactobacillus strain in children with atopic dermatitis. J Allergy Clin Immunol. 2003;111:389-395. (Pubitemid 36228562)
23. Betsa GI, Papadavid E, Falagas ME. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol. 2008;9:93-103. (Pubitemid 351280953)
24. Boyle RJ, Tang MLK. The role of probiotics in the management of allergic disease. Clin Exp Allergy. 2006;36:568-576.
25. Drago L, Nicola L, Iemoli E, et al. Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model. BMC Res Notes. 2010;3:44.
26. Li Cy Lin HC, Hsueh KC, et al. Oral administration of Lactobacillus salivarius inhibits the allergic airway response in mice. Can J Microbiol. 2010;56:373-379.
27. Valsecchi C, Marseglia A, Ricci A, et al. Probiotics and children: is an integration useful in allergic diseases? Pediatr Med Chir. 2008;30:197-203.
28. Chagnaud P, Machinis K, Coutte AL, et al. Rapid PCR-based procedure to identify lactic acid bacteria: application to six common Lactobacillus species. J Microbiol Met. 2001;44: 139-148. (Pubitemid 32124780)
29. Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy. 2004;59:86-92. (Pubitemid 39005854)
30. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis; the SCORAD index. Dermatology. 1993;186:23-31.
31. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216. (Pubitemid 24194579)
32. Aureli P, Fiore A, Scalfaro C, et al. Metodi microbiologici tradizionali e metodi molecolari per l'analisi degli integratori alimentari a base di o con integratori per uso umano. [Traditional microbiological methods and molecular methods for the analysis of probiotic food supplements for human use]. Rapporti ISTISAN 08/36. 2008;1-58.
33. Wall R, Fitzgerald G, Hussey S, et al. Genomic diversity of cultivable Lactobacillus populations residing in the neonatal and adult gastrointestinal tract. FEMS Microbiol Ecol. 2007;59:127-137. (Pubitemid 44952415)
34. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003;112:S118-S127. (Pubitemid 37550028)
35. Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T-helper type (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med. 1993;77: 1199-1204. (Pubitemid 23097410)
36. Pène J, Rousset F, Brière F, et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A. 1988;85:6880-6884.
37. Mordvinov VA, Sanderson CJ. Regulation of IL-5 expression. Arch Immunol Ther Exp. 2001;49:345-351.
38. Pascolini C, Sinagra J, Pecetta S, et al. Molecular and immunological characterization of Staphylococcus aureus in pediatric atopic dermatitis: implications for prophylaxis and clinical management. Clin Dev Immunol. 2011;2011.
39. Arslanagic N, Arslanagic R. Atopic dermatitis and Staphylococcus aureus. Med Arh. 2004;58:363-365.
40. Goh CL, Wong JS, Giam YC. Skin colonization of Staphylococcus aureus in atopic dermatitis patients sees at the national skin centre. Int J Dermatol. 1997;36:653-657. (Pubitemid 27452147)
41. Williams REA, Gibson AG, Aitchison TC, et al. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol. 1990;123:493-501. (Pubitemid 20344790)
42. Higaki S, Morohashi M, Yamagishi T, et al. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol. 1999;38: 265-269. (Pubitemid 29189630)
43. Sharp MJ, Rowe J, Kusel M, et al. Specific patterns of responsiveness to microbial antigens staphylococcal enterotoxin B and purified protein derivative by cord blood mononuclear cells are predictive of risk for development of atopic dermatitis. Clin Exp Allergy. 2003;33:435-441. (Pubitemid 36520905)
44. Nomura I, Tanaka K, Tomita H, et al. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol. 1999;104:441-446. (Pubitemid 29420444)
45. Higaki S, Morohashi M, Yamagishi T, et al. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol. 1999;38:265-269. (Pubitemid 29189630)
46. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut. 2005;54:317-320. (Pubitemid 40299080)